Evidence map›Paper›PMID 30642264›Full record

ArticleBMC family practice2019

Effectiveness of treatment of newly diagnosed hypertension in family medicine practices in South Croatia.

Diana Jurić, Ivančica Pavličević, Ana Marušić, Mario Malički, Ivan Buljan, Velen Šarotić, Nataša Mrduljaš-Đujić, Ante Komparak, Miona Vujević, Danijela De Micheli-Vitturi and 5 more

Abstract read
In one paragraph

Article in BMC family practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Diana JurićDepartment of Pharmacology, University of Split School of Medicine, Šoltanska 2, Split, Croatia. diana.juric26@gmail.com.ORCID 0000-0002-1846-2540
Ivančica PavličevićDepartment of Family Medicine, University of Split School of Medicine, Split, Croatia.
Ana MarušićDepartment of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.
Mario MaličkiDepartment of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.
Ivan BuljanDepartment of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.
Velen ŠarotićFamily medicine practice, Lećevica, Croatia.
Nataša Mrduljaš-ĐujićDepartment of Family Medicine, University of Split School of Medicine, Split, Croatia.
Ante KomparakFamily medicine practice, Korčula, Croatia.
Miona VujevićFamily medicine practice, Imotski, Croatia.
Danijela De Micheli-VitturiFamily medicine practice, Split, Croatia.
Pjera ŠušnjarFamily medicine practice, Pučišća, Croatia.
Tina PuljizFamily medicine practice, Runovići, Croatia.
Minka JerčićFamily medicine practice, Donji Muć, Croatia.
Dario LeskurDepartment of Pharmacy, University of Split School of Medicine, Split, Croatia.
Matko MarušićDepartment of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUncontrolled blood pressure remains an urgent issue in clinical practice worldwide. This study aimed to compare the characteristics and effectiveness of hypertension control in family medicine pratice in the first treatment year, in relation to the geographical position, socio-economic standard, and access to medical services and public pharmacies in urban, rural and island environments (city of Split vs. Dalmatian Hinterland vs. islands in Southern Croatia).

methodsA historical cohort study included 213 patients diagnosed from 2008 to 2014 with essential arterial hypertension (AH) and without related complications or diabetes mellitus. Each patient was followed up for 365 days from the visit when the diagnosis of hypertension was ascertained. Normotension was defined as arterial pressure < 140/90 mmHg. The annual cost of drugs prescribed for treating newly diagnosed hypertensive patient and the total price for defined daily dose per patient were also evaluated.

resultsMore than half patients achieved normotension within a year from the initial diagnosis in all family medicine practices (57.3%), without significant differences among the three geographic regions (P = 0.981). Higher initial systolic blood pressure was a positive predictive prognostic factor on achieveing normotension (odds ratio (OR) 0.96, 95% confidence interval 0.95-0.98). ACE inhibitors were the most commonly prescribed antihypertensive agents in monotherapy (35.1%), as well as considering overall prescriptions (25.2%). Calcium channel blockers were the most commonly prescribed initial BP-lowering single agents in urban areas (28.6%), whereas angiotensin-converting enzyme inhibitors were more common in rural (28.0%) and island areas (22.7%) (P = 0.037). The median annual antihypertensive drug cost was 169.4 (95% CI 151.5-201.8) Croatian kunas and was similar across the study sites.

conclusionMultiple antihypertensive drugs, prescribed in accordance with the guidelines, lead to similar pharmacological effects. Primary care physicians seem to be able to overcome potential interfering socio-economic factors and successfully achieve normotension in newly diagnosed patients with uncomplicated AH after 1 year of treatment.

Indexed as

Family PracticeAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsCalcium Channel BlockersCroatiaDrug CostsFemaleHumansHypertensionMaleMiddle AgedPrognosisRural PopulationTreatment OutcomeUrban PopulationAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsCalcium Channel BlockersArterial hypertensionBlood pressureControlHypertension treatmentIslandNormotensionRuralUrban

Identifiers

PMID30642264
PMCPMC6330736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.